CureVac NV (Germany) Probability of Future Stock Price Finishing Over 12.48
| 5CV Stock | EUR 3.06 0.02 0.65% |
CureVac |
CureVac NV Target Price Odds to finish over 12.48
The tendency of CureVac Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 12.48 or more in 90 days |
| 3.06 | 90 days | 12.48 | close to zero percent |
Based on a normal probability distribution, the odds of CureVac NV to move over € 12.48 or more in 90 days from now is close to zero percent (This CureVac NV probability density function shows the probability of CureVac Stock to fall within a particular range of prices over 90 days) . Probability of CureVac NV price to stay between its current price of € 3.06 and € 12.48 at the end of the 90-day period is about 1.48 .
Assuming the 90 days horizon CureVac NV has a beta of -0.28. This suggests as returns on the benchmark increase, returns on holding CureVac NV are expected to decrease at a much lower rate. During a bear market, however, CureVac NV is likely to outperform the market. Additionally CureVac NV has an alpha of 0.1986, implying that it can generate a 0.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CureVac NV Price Density |
| Price |
Predictive Modules for CureVac NV
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CureVac NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CureVac NV Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CureVac NV is not an exception. The market had few large corrections towards the CureVac NV's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CureVac NV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CureVac NV within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | -0.28 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | 0.02 |
CureVac NV Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CureVac NV for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CureVac NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CureVac NV had very high historical volatility over the last 90 days | |
| The company reported the revenue of 102.99 M. Net Loss for the year was (411.72 M) with loss before overhead, payroll, taxes, and interest of (135.09 M). | |
| CureVac NV has accumulated about 1.33 B in cash with (733.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 46.0% of the company shares are owned by insiders or employees |
CureVac NV Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CureVac Stock often depends not only on the future outlook of the current and potential CureVac NV's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CureVac NV's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 187.1 M |
CureVac NV Technical Analysis
CureVac NV's future price can be derived by breaking down and analyzing its technical indicators over time. CureVac Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CureVac NV. In general, you should focus on analyzing CureVac Stock price patterns and their correlations with different microeconomic environments and drivers.
CureVac NV Predictive Forecast Models
CureVac NV's time-series forecasting models is one of many CureVac NV's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CureVac NV's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about CureVac NV
Checking the ongoing alerts about CureVac NV for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CureVac NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| CureVac NV had very high historical volatility over the last 90 days | |
| The company reported the revenue of 102.99 M. Net Loss for the year was (411.72 M) with loss before overhead, payroll, taxes, and interest of (135.09 M). | |
| CureVac NV has accumulated about 1.33 B in cash with (733.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 46.0% of the company shares are owned by insiders or employees |
Additional Information and Resources on Investing in CureVac Stock
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out CureVac NV Backtesting, CureVac NV Valuation, CureVac NV Correlation, CureVac NV Hype Analysis, CureVac NV Volatility, CureVac NV History as well as CureVac NV Performance. For more detail on how to invest in CureVac Stock please use our How to Invest in CureVac NV guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.